# Safety and Tolerability of 200mg and 100mg of Venofer Administered to Hemodialysis(HD) Patients

> **NCT06690450** · PHASE4 · COMPLETED · sponsor: **American Regent, Inc.** · enrollment: 400 (actual)

## Conditions studied

- Hemodialysis

## Interventions

- **DRUG:** Venofer® 200 mg
- **DRUG:** Venofer® 100 mg

## Key facts

- **NCT ID:** NCT06690450
- **Lead sponsor:** American Regent, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08
- **Primary completion:** 2002-01
- **Final completion:** 2002-02
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2024-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06690450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06690450, "Safety and Tolerability of 200mg and 100mg of Venofer Administered to Hemodialysis(HD) Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06690450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*